Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
anticoagulant citrate phosphate double dextrose solution
- Development stage
- Unknown
- Lead developer
- Haemonetics
- Modality
- Small Molecules
- Administration
- Extracorporeal
01
Overview
Anticoagulant citrate phosphate double dextrose solution (CP2D) is a **sterile, non-pyrogenic solution** containing citric acid monohydrate, trisodium citrate dihydrate, monobasic sodium phosphate monohydrate, and anhydrous dextrose, formulated as an anticoagulant for **the collection and preservation of human blood and blood components during automated apheresis procedures**[1][3][4]. The citrate ions chelate calcium, effectively inhibiting coagulation by interrupting the calcium-dependent steps of the clotting cascade. CP2D is not intended for direct infusion and does not produce a systemic pharmacological effect. It is used exclusively in medical or blood bank settings with apheresis devices to safely collect red blood cells and plasma for transfusion or laboratory analysis[1][4].
- Brand names
- Leukotrap
- Other names
- Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution
Beyond the preview
Go deeper on anticoagulant citrate phosphate double dextrose solution.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on anticoagulant citrate phosphate double dextrose solution.